| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 26.3 | 14.8 | 8.5 |
| Other income | 0.0 | 0.0 | 0.1 |
| Total income | 26.3 | 14.8 | 8.6 |
| Profit before exceptional items & tax | 0.1 | 0.5 | 0.2 |
| Profit before tax | 0.1 | 0.5 | 0.2 |
| Net profit | 0.1 | 0.3 | 0.2 |
| Operating margin | 0.4% | 3.4% | 2.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -50.00% |
|---|---|
| Net profit, quarter on quarter | -66.70% |
| Revenue, year on year | +209.40% |
BSE results filing, NSE: SHIVMED. Figures extracted from the filing.
Bandaram Pharma Packtech Ltd: key numbers
- Share price
- ₹20.49
- Market cap
- ₹36.82 Cr
- Revenue (annual)
- ₹62.92 Cr
- Net profit (annual)
- ₹1.01 Cr
- P/E (TTM)
- 36.2×Sector 57.8×
- Promoter holding
- 62.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bandaram Pharma Packtech Ltd
All →Bandaram Pharma Packtech Board Meeting Date
Bandaram Pharma Packtech has scheduled a board meeting on 30.09.2026 to consider a proposal for a scheme of arrangement or amalgamation.
Bandaram Pharma Packtech Annual General Meeting
Bandaram Pharma Packtech Limited held its Annual General Meeting on September 24, 2026, approving financial statements and re-appointing auditors and directors.
Bandaram Pharma Packtech Q1 FY27 Results: Net Profit ₹0.7 Cr, Up 600.0% QoQ
Bandaram Pharma Packtech Ltd reported revenue from operations of ₹24 Cr (+196.3% YoY) and net profit of ₹0.7 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.7 Cr